20th – 22nd October 2014
London, UK
This event has an open poster session. Posters can be submitted on any subject related to vaccines and vaccination
Abstracts for poster presentation only can be submitted up to two weeks before the event
.
You can download the instructions for authors at
www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
www.regonline.co.uk/vaccines2014
This year there are three main topics for discussion
- Next Generation Vaccines: Adjuvants and delivery systems
- Modulation the Immune System for Vaccination
- Advances in overcoming co-infections
- The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding vaccines and vaccination.
Talks Include:
The Next Generation of Vaccines, Adjuvants, and Delivery Systems: Lessons from the Past 50 Years Dr Lawrence Dean Frenkel, Professor, Departments of Pediatrics and Microbiology, University of Illinois, USAThe state of HIV-1 co-infection The introductory talk will briefly outline current understanding of major HIV-1 co-infections. Mr Christopher Ward, PhD Student,Innate Immune Sensors Group, Institute of Infection & Immunity, Cardiff University School of Medicine, University Hospital of Wales Optimizing delivery of next generation immune potentiators DNA Vaccination Encoding CD40 Targeted to Dendritic Cells Protects Against Chronic Kidney Disease. Tubular immunostimulating complex based on glycolipid and saponin from marine hydrobiont Virus Related Cancer In Immunosuppressed Individuals Talk title to be confirmed Talk to be confirmed Talk to be confirmed Pseudotypes versus traditional Virus Neutralization, advantage and future perspectives: Development of Dissolvable Microneedle Patches for Skin-based Immunization Modular, adaptable Nanoparticle-based vaccines and applications: SMARTer Vaccines: Next-Generation Vaccinia Virus Vaccine and Therapeutic Vectors: Angiotensin and Systems Thinking, Wrapping your mind around the big picture: Improving the cellular immune response obtainable by adenovirus vectored vaccines Hazard Group 4 Agents: Wild, Tamed & In Disguise Protein nanoparticles with built-in adjuvant properties The combined effects of genetic background and mannose-binding lectin ligands on the response to an avian coronavirus vaccination Adeno-Associated viral (AAV) pseudotyping as a tool for gene therapy and genetic vaccine applications Competition: Issues in the Distribution of the Health Care Workforce in Administering Vaccines Stable HIV-based pseudotype particles and sugar antigen display on retroviral pseudotype particles Evaluation of a pseudotyped lentivirus-based neutralisation assay for potency testing of rabies immunoglobulins Immunomodulation through lipopeptide structure-activity relationships for the development of a synthetic self-adjuvanting Group A streptococcus vaccine candidate |